Evaluate Now for Suspected or Known Vesicoureteral Reflux

LUMASON is the first and only FDA-approved CEUS agent indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux.1

Scan

Ultrasound image is reprinted with permission from Pediatric Radiology.2 Individual results may vary.

The effectiveness in pediatric patients has been established for use in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux from two published studies comprising a total of 411 pediatric patients. Safety of intravesical use of LUMASON was based on the evaluation of published literature involving the use of LUMASON in over 6000 pediatric patients. No adverse reactions were reported.1

Urologist

The individuals who appear are for illustrative purposes only.